Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology.
$1.07
As of 05/20/2022 IEX book CBOE book
2022 © Stock Market MBA, Inc.